Cleveland v. Janssen Pharmaceuticals

Filing 123

ORDER signed by Senior Judge Morrison C. England, Jr. on 9/2/2020 ADOPTING in FULL 122 Findings and Recommendations, and DENYING 121 Motion for Reconsideration. (Reader, L)

1
2
3
4
5
6
7
8

UNITED STATES DISTRICT COURT

9

FOR THE EASTERN DISTRICT OF CALIFORNIA

10
11

DOMINGO L. CLEVELAND, SR.,

12

Plaintiff,

13
14

No. 2:16-cv-02308 MCE AC

v.

ORDER

JANSSEN PHARMACEUTICALS,

15

Defendant.

16
Plaintiff, proceeding pro se, filed the above-entitled action. The matter was referred to a

17
18

United States Magistrate Judge pursuant to Local Rule 302(c)(21).
On July 22, 2020, the magistrate judge filed findings and recommendations herein which

19
20

were served on all parties and which contained notice to all parties that any objections to the

21

findings and recommendations were to be filed within twenty-one. Neither party has filed

22

objections to the findings and recommendations.
The court has reviewed the file and finds the findings and recommendations to be

23
24

supported by the record and by the magistrate judge’s analysis. Accordingly, IT IS HEREBY

25

ORDERED that:
1. The findings and recommendations filed July 22, 2020, (ECF No. 122) are ADOPTED

26

in full; and

27
28

///
1

1

2. Plaintiff’s motion for reconsideration (ECF No. 121) is DENIED.

2

IT IS SO ORDERED.

3

Dated: September 2, 2020

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
2